Search results
Illumina's board approves to spin off Grail in June By Reuters
Investing.com· 3 days agoShareholders will receive one common share of Grail for every six shares of Illumina (NASDAQ:ILMN),...
Illumina to spin off early cancer detection test maker Grail after ill-fated $8 billion acquisition...
The Business Journals· 1 day agoMore than three years after planning its own initial public offering, early cancer detection test...
Grail to become an Illumina spinout once again, as divestment plan moves forward
FierceBiotech· 3 days agoThe company’s board of directors has approved the plan for Grail to join the Nasdaq, under the...
Illumina shares hold rating from Jefferies By Investing.com
Investing.com· 3 days agoOn Monday, Jefferies began covering Illumina, Inc. (NASDAQ:ILMN), a leading company in...
Illumina sets date for GRAIL spin-off and share distribution By Investing.com
Investing.com· 3 days agoIllumina Inc. (NASDAQ:ILMN), a global leader in DNA sequencing technologies, has announced the...
Illumina to Spin off Grail by Issuing Shares to Investors, Will Keep 14.5 Percent
GenomeWeb News· 3 days agoIllumina will issue one share of Grail to investors for every six shares of Illumina stock and will retain a 14.5 percent stake in Grail. Investors will ...
Thomas Kean Jr. makes moves in Illumina and Nike stocks By Investing.com
Investing.com· 6 days agoIn a recent congressional trade report, Thomas Kean Jr., representing New Jersey's 7th congressional...
Illumina (NASDAQ:ILMN) Now Covered by Analysts at Jefferies Financial Group
ETF DAILY NEWS· 3 days agoEquities research analysts at Jefferies Financial Group initiated coverage on shares of Illumina (NASDAQ:ILMN – Get Free Report) in a research report issued ...
Illumina approves Grail spinoff plan
Axios· 2 days agoThis ends a long antitrust battle, with Grail to begin trading as an independent company later this month.
San Diego gene-sequencer Illumina spins off blood testing startup Grail — for the second time
U-T San Diego· 2 days agoSan Diego gene-sequencing giant Illumina said Monday that its board approved the spinoff of early...